Skip to main content
. 2018 Apr 18;2018(4):CD001841. doi: 10.1002/14651858.CD001841.pub3

Comparison 3. First‐line ACE inhibitor vs Placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Total mortality 3 6002 Risk Ratio (M‐H, Fixed, 95% CI) 0.83 [0.72, 0.95]
2 Total stroke 3 6002 Risk Ratio (M‐H, Fixed, 95% CI) 0.65 [0.52, 0.82]
3 Total coronary heart disease 2 5145 Risk Ratio (M‐H, Fixed, 95% CI) 0.81 [0.70, 0.94]
4 Total cardiovascular events 2 5145 Risk Ratio (M‐H, Fixed, 95% CI) 0.76 [0.67, 0.85]
5 Systolic blood pressure 2 1071 Mean Difference (IV, Fixed, 99% CI) ‐21.14 [‐23.13, ‐19.15]
6 Diastolic blood pressure 2 1071 Mean Difference (IV, Fixed, 99% CI) ‐9.64 [‐10.70, ‐8.58]